此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Tissue Sensor for Semirigid Thulium Fiber Laser Ureterolithotripsy (Tissue Sensor)

2026年9月17日 更新者:Malkhasyan Vigen Andreevich、Botkin Hospital

Tissue Sensor to Reduce Laser-Induced Ureteral Injury During Semirigid Thulium Fiber Laser Ureterolithotripsy: The TISSUE Multicenter Randomized Controlled Trial

Tissue Sensor (TS) is a technology designed to automatically deactivate laser emission when contact between the laser fiber and tissue is detected. It is hypothesized that the use of TS during contact laser ureterolithotripsy may reduce unintended laser exposure of the ureteral mucosa, thereby decreasing the risk of immediate thermal injury to the ureteral wall and subsequent scar-related narrowing.

To reduce the influence of baseline risk factors for stricture, the study will enroll a homogeneous population of patients without urinary tract anomalies, previous surgery on the study ureter, or impacted stones. The procedure will be performed according to a standardized protocol using a semirigid ureteroscope, a thulium fiber laser, and predefined technical restrictions. The study is limited to patients with stones in the mid or distal ureter. This approach is intended to minimize the likelihood of stone retropulsion into the kidney, standardize the surgical technique, reduce the need for conversion to flexible ureteroscopy, and maximize comparability between the study groups.

研究概览

研究类型

介入性

注册 (估计的)

121

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • • Age 18 years or older.

    • A single stone in the mid or distal ureter.
    • Maximum stone diameter of 15 mm or less on preoperative CT.
    • An indication for elective semirigid laser ureterolithotripsy.
    • Feasibility of performing the procedure with a semirigid ureteroscope.
    • No active urinary tract infection at the time of the intervention.
    • Ability to undergo CT follow-up and complete 12 months of follow-up.
    • Signed written informed consent.

Exclusion Criteria:

  • • Age 18 years or older.

    • A single stone in the mid or distal ureter.
    • Maximum stone diameter of 15 mm or less on preoperative CT.
    • An indication for elective semirigid laser ureterolithotripsy.
    • Feasibility of performing the procedure with a semirigid ureteroscope.
    • No active urinary tract infection at the time of the intervention.
    • Ability to undergo CT follow-up and complete 12 months of follow-up.
    • Signed written informed consent.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Patients after ureterolithotrypsy with Tissue Sensor activated

Semirigid TFL ureterolithotripsy will be performed with Tissue Sensor activated. All automatic system trigger events will be recorded by the laser system or in the study case report form and, whenever possible, synchronized with the procedure video recording

Semirigid TFL ureterolithotripsy will be performed with Tissue Sensor activated. All automatic system trigger events will be recorded by the laser system or in the study case report form and, whenever possible, synchronized with the procedure video recording

实验性的:Patients after ureterolithotrypsy with Tissue Sensor deactivated

Semirigid TFL ureterolithotripsy will be performed with Tissue Sensor deactivated. Visually confirmed contacts between the activated laser fiber and the ureteral mucosa will be recorded from the procedure video

Semirigid TFL ureterolithotripsy will be performed with Tissue Sensor deactivated. Visually confirmed contacts between the activated laser fiber and the ureteral mucosa will be recorded from the procedure video.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Incidence of intraoperative laser-induced injury to the ureteral mucosa
大体时间:intraoperative

Incidence of intraoperative laser-induced injury to the ureteral mucosa, defined as any visible injury compatible with exposure to an activated laser fiber, as determined by independent blinded video assessment.

intraoperative

次要结果测量

结果测量
措施说明
大体时间
Incidence of postoperative ureteral stricture
大体时间:12 months.

Incidence of postoperative ureteral stricture detected during the 12 months after the intervention.

  • Stone-free rate on low-dose non-contrast CT at 1 month.
  • Incidence and total number of Tissue Sensor trigger events in the TS group.
  • Incidence and total number of visually confirmed contacts between an activated laser fiber and the mucosa in the control group.
  • Number of trigger events or contacts per minute of laser activation.
  • Severity of mucosal injury according to the standardized scale.
  • Total operative time.
  • Lithotripsy time.
  • Cumulative laser activation time.
  • Migration of the stone or fragments into the kidney.
  • Need for conversion to flexible ureteroscopy or repeat intervention.
  • Type and duration of postoperative drainage.
  • Postoperative complications according to the Clavien-Dindo classification.
  • New or progressive hydronephrosis during follow-up.
12 months.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年10月1日

初级完成 (估计的)

2028年10月1日

研究完成 (估计的)

2028年11月2日

研究注册日期

首次提交

2026年9月17日

首先提交符合 QC 标准的

2026年9月17日

首次发布 (实际的)

2026年9月22日

研究记录更新

最后更新发布 (实际的)

2026年9月22日

上次提交的符合 QC 标准的更新

2026年9月17日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅